Study to Evaluate the Effect of a Single Oral Dose of MT-7117 on the QT/QTc Interval in Healthy Subjects
Clinical trial NCT05241535 · COMPLETED
Trial details
- NCT number
- NCT05241535
- Sponsor
- Tanabe Pharma America, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-12
- Primary completion
- 2022-02-23
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.